| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Edwin Bremer | Q39507482 |
| P2093 | author name string | W Helfrich | |
| W F A den Dunnen | |||
| J M A Kuijlen | |||
| J J A Mooij | |||
| P2860 | cites work | NK cell TRAIL eliminates immature dendritic cells in vivo and limits dendritic cell vaccination efficacy | Q33974774 |
| Convection-enhanced delivery of interleukin-13 receptor-directed cytotoxin for malignant glioma therapy | Q36478656 | ||
| Differential secretion of Fas ligand- or APO2 ligand/TNF-related apoptosis-inducing ligand-carrying microvesicles during activation-induced death of human T cells | Q40764496 | ||
| P433 | issue | 3 | |
| P304 | page(s) | 168-182 | |
| P577 | publication date | 2010-01-20 | |
| P1433 | published in | Neuropathology and Applied Neurobiology | Q7002494 |
| P1476 | title | Review: on TRAIL for malignant glioma therapy? | |
| P478 | volume | 36 |
| Q38453709 | An integrated transcriptomic and computational analysis for biomarker identification in human glioma |
| Q35653261 | Antiangiogenic variant of TSP-1 targets tumor cells in glioblastomas |
| Q30724766 | BAFF, APRIL, TWEAK, BCMA, TACI and Fn14 proteins are related to human glioma tumor grade: immunohistochemistry and public microarray data meta-analysis |
| Q36809469 | BNIP3 acts as transcriptional repressor of death receptor-5 expression and prevents TRAIL-induced cell death in gliomas |
| Q60928004 | Caspase-8: A Novel Target to Overcome Resistance to Chemotherapy in Glioblastoma |
| Q37096238 | Characterization of MUDENG, a novel anti-apoptotic protein |
| Q39069742 | Combination treatment for glioblastoma cells with tumor necrosis factor-related apoptosis-inducing ligand and oncolytic adenovirus delta-24. |
| Q48197073 | Combination treatment of TRAIL, DFMO and radiation for malignant glioma cells |
| Q39639739 | Efficient Melanoma Cell Killing and Reduced Melanoma Growth in Mice by a Selective Replicating Adenovirus Armed with Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand |
| Q92461964 | Gene Expression of Molecules Regulating Apoptotic Pathways in Glioblastoma Multiforme Treated with Umbilical Cord Stem Cell Conditioned Medium |
| Q34028464 | Genetically engineered Newcastle disease virus expressing interleukin-2 and TNF-related apoptosis-inducing ligand for cancer therapy |
| Q90066149 | Glioma malignancy is linked to interdependent and inverse AMOG and L1 adhesion molecule expression |
| Q38863325 | Glioma-astrocyte interactions on white matter tract-mimetic aligned electrospun nanofibers. |
| Q24302531 | Histone deacetylase inhibitors sensitize glioblastoma cells to TRAIL-induced apoptosis by c-myc-mediated downregulation of cFLIP |
| Q38921239 | Icaritin Sensitizes Human Glioblastoma Cells to TRAIL-Induced Apoptosis |
| Q34063254 | Immunocytochemical studies on the effect of 405-nm low-power laser irradiation on human-derived A-172 glioblastoma cells |
| Q92013024 | Implementing Patient-Derived Xenografts to Assess the Effectiveness of Cyclin-Dependent Kinase Inhibitors in Glioblastoma |
| Q36582394 | Influence of far upstream element binding protein 1 gene on chemotherapy sensitivity in human U251 glioblastoma cells. |
| Q38648551 | Intranasal delivery of mesenchymal stem cells significantly extends survival of irradiated mice with experimental brain tumors |
| Q40823291 | MiR-34a regulates blood-tumor barrier function by targeting protein kinase Cε. |
| Q37610475 | Modulation of Mcl-1 sensitizes glioblastoma to TRAIL-induced apoptosis |
| Q36866011 | NPV-LDE-225 (Erismodegib) inhibits epithelial mesenchymal transition and self-renewal of glioblastoma initiating cells by regulating miR-21, miR-128, and miR-200 |
| Q37585453 | Potential application of temozolomide in mesenchymal stem cell-based TRAIL gene therapy against malignant glioma |
| Q28537942 | Salinomycin potentiates the cytotoxic effects of TRAIL on glioblastoma cell lines |
| Q46420694 | Sea Buckthorn Leaf Extract Inhibits Glioma Cell Growth by Reducing Reactive Oxygen Species and Promoting Apoptosis |
| Q37028654 | Systemically administered AAV9-sTRAIL combats invasive glioblastoma in a patient-derived orthotopic xenograft model. |
| Q36197395 | TRAIL and paclitaxel synergize to kill U87 cells and U87-derived stem-like cells in vitro. |
| Q50054799 | TRAIL-Induced Apoptosis in TRAIL-Resistant Breast Carcinoma Through Quercetin Cotreatment |
| Q39056037 | Targeted induction of apoptosis in glioblastoma multiforme cells by an MRP3-specific TRAIL fusion protein in vitro |
| Q61796847 | Targeting KPNB1 overcomes TRAIL resistance by regulating DR5, Mcl-1 and FLIP in glioblastoma cells |
| Q36640628 | β-catenin knockdown inhibits the proliferation of human glioma cells in vitro and in vivo |
Search more.